Skip to main content
IRON logo

Disc Medicine, Inc.

IRONNASDAQHealthcareBiotechnology

$56.65Today:- (-)1Y −23.82%

As of Oct 15, 2026 close

Market cap
$2.19B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$40.00$99.50
Volume (live)
-
Avg. volume (3M)
610.19K

Disc Medicine (IRON) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Disc Medicine used $180.39M of cash in operating activities and spent $933.00K on capital expenditures. That left free cash flow of −$181.33M.

Disc Medicine Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Disc Medicine, Inc. (IRON) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2022FY 2021FY 2020
Period endingDec 2025Dec 2024Dec 2023Mar 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-212.18-109.36-76.43-46.83-46.83-35.97-40.84
Depreciation & Amortization0.280.160.100.090.090.030.32
Stock Based Compensation34.3416.825.532.092.090.510.98
Change in Working Capital3.533.23-2.952.132.131.290.34
Change in Accounts Payable1.07-4.68-3.740.530.531.32-2.41
Change in Other Working Capital2.467.910.291.600.21-0.032.75
Other Operating Activities-6.36-4.770.290.270.216.616.49
Net Cash from Operating Activities-180.39-93.93-73.46-42.25-42.25-27.53-32.71
Investing Activities
Capital Expenditures-0.93-0.51-0.09-0.15-0.15-0.07-0.02
Purchases of Investments-849.59-386.630.000.00-0.000.00
Sales/Maturities of Investments456.2294.800.000.00-0.000.00
Net Cash from Investing Activities-394.30-292.33-0.09-0.15-0.15-0.07-0.02
Financing Activities
Debt Repayment0.0028.990.000.00--4.5814.00
Common Stock Issued472.83187.30199.0853.5053.500.000.00
Other Financing Activities0.582.0237.5895.4895.2694.5120.25
Net Cash from Financing Activities473.41218.31239.38148.98148.9889.9334.25
Summary
Net Change in Cash-101.29-167.94165.83106.58106.5862.331.52
Cash at Beginning of Period192.67360.62194.7988.2188.2125.893.31
Cash at End of Period91.39192.67360.62194.79194.7988.214.83
Free Cash Flow-181.33-94.43-73.55-42.40-42.40-27.60-32.73
Supplemental Disclosures
Interest Paid-0.20-----
Income Taxes Paid-0.300.11----

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Disc Medicine Cash Flow

What is Disc Medicine's free cash flow?

Disc Medicine had negative free cash flow of $181.33M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$180.39M minus $933.00K of capital expenditures.

How much does Disc Medicine spend on capital expenditures?

Disc Medicine spent $933.00K on capital expenditures in fiscal 2025, compared with $505.00K a year earlier.

Does Disc Medicine pay dividends or buy back shares?

Disc Medicine's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition